SB 936 Pennsylvania Senate · 2025-2026 Regular Session

An Act requiring health insurance policies to provide coverage for postexposure prophylaxis HIV medication.

SB 936, the "PEP for Pennsylvania Act," requires all health insurance policies sold in Pennsylvania to cover the cost of postexposure prophylaxis (PEP) HIV medication - FDA-approved drugs taken after potential HIV exposure to prevent infection. It mandates this coverage for all qualifying health insurance plans (excluding dental, vision, or limited benefit policies) starting 60 days after the law takes effect, and prohibits insurers from placing PEP medications in higher-cost specialty tiers solely for profit. The bill also prevents insurers from requiring unnecessary counseling from infectious disease specialists to access PEP, unless medically needed. This directly affects Pennsylvania residents with health insurance by ensuring access to critical HIV prevention medication without financial barriers.
Bill status in committee 1 of 4 stages cleared
Introduction
Jul 2025
Committee Review
Floor Vote
Governor
Introduced Jul 22, 2025 Last action Jul 22, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
1
Jul 22, 2025
Committee
Referred to Banking & Insurance
upper
1 primary · 11 co-sponsors

Sponsors